Senior Scientist
Janssen Research and Development
Spring House, Pennsylvania
Dr. Karan Agrawal is a Senior Scientist in the Bioanalytical Discovery and Development Sciences team within the Preclinical Sciences and Translational Safety organization at Janssen Research and Development in Spring House, Pennsylvania. In this role, Karan focuses on the development and application of LC-MS bioanalytical assays for the quantitative assessment of large and small molecule biomarkers and drug candidates, focusing on novel modalities. Dr. Agrawal also drives innovation at Janssen, evaluating new analytical technologies and sample preparation approaches to help answer challenging biological questions.
Prior to joining Janssen, Karan was a Staff Scientist at Labcorp Drug Development in Indianapolis, Indiana, where he conducted bioanalytical method development and validation for small and large molecule analytes by LC-MS/MS. Dr. Agrawal earned a B.A. in Chemistry and Molecular Biology from Cornell University, an M.Sc. in Forensic Science from King’s College London, and a Ph.D. in Pharmacology and Toxicology from the University of California-Davis.
Disclosure information not submitted.
Comparison of Four Bioanalytical Assay Platforms for siRNA Therapeutic Quantitation
Wednesday, May 15, 2024
3:00 PM – 3:15 PM PT